Healthy Living/WellnessAdvaxis’ Experimental Cancer Immunotherapy Axalimogene Filolisbac Boosts Survival Rates In Cervical Cancer Patients Advaxis Inc.'s new experimental vaccine was tested by a separate group and was found to prolong metastatic cervical cancer patients' lifespans by one year.by Julienne Roman
Healthy Living/WellnessMedical Experts Speak Out About GOP Vaccine Claims In Recent Debateby Rina Marie Doctor
Healthy Living/WellnessPassive Smoking Increases Diabetes Risks By 22 Percent: How To Reduce Exposure To Secondhand Smokeby Katherine Derla
Healthy Living/WellnessUniversal Health Services Shelling Out $350M To Buy Addiction Treatment Company Foundations Recovery Networkby Katherine Derla
Healthy Living/WellnessWoman Suffering From Severe Headache Has Tapeworm Eggs in Her Brainby Katherine Derla
Healthy Living/WellnessU.S. Health Officials: No More Ebola Screening For Travelers From Liberiaby Rina Marie Doctor
Healthy Living/WellnessMold At Pittsburgh Hospital May Have Contributed To Death Of Two Patientsby Katherine Derla
Healthy Living/WellnessFDA Gives Fast Track Approval To ZMapp Experimental Ebola Drugby Rina Marie Doctor
Healthy Living/WellnessCalculator Tells How Many Sexual Partners You Had And There May Be More Than What You Thinkby Julienne Roman